Literature DB >> 27914806

Interprovincial Differences in Canadian Coronary Care Unit Resource Use and Outcomes.

Sean van Diepen1, Meng Lin2, Justin A Ezekowitz3, Finlay A McAlister4, Douglas S Lee5, Shaun G Goodman6, Paul W Armstrong3, Padma Kaul7.   

Abstract

International registries have reported a wide variation in coronary care unit (CCU) admission rates for patients hospitalized with acute coronary syndrome (ACS) or heart failure (HF). Little is known about variation in Canadian interprovincial use and outcomes. Canadian Institute of Health Information data were used to identify hospitalized patients admitted to a CCU with a primary diagnosis of ACS or HF between April 1, 2007 and March 31, 2013. We examined interprovincial differences in CCU admission rates, use of CCU restricted therapies in the first 2 days of admission, and the association between CCU admission rate and risk-adjusted in-hospital mortality at the provincial level. The CCU admission rate among 220,759 patients hospitalized with ACS and HF was 33%, and this varied significantly across provinces (interprovincial range [IPR] 17%-50%; P < 0.001). A majority (59%; IPR, 48%-84%; P < 0.001) of patients admitted to the CCU did not receive critical care restricted therapies within 2 days. In-hospital mortality also varied across provinces (10%; IPR, 5%-13%; P < 0.001). Although statistically significant (P < 0.001), the correlation between CCU admission rates and provincial risk-adjusted in-hospital mortality was low (r = -0.30). These findings highlight the need for national CCU admission criteria designed to reduce variability and improve health care resource use and outcomes.
Copyright © 2016 Canadian Cardiovascular Society. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2016        PMID: 27914806     DOI: 10.1016/j.cjca.2016.10.009

Source DB:  PubMed          Journal:  Can J Cardiol        ISSN: 0828-282X            Impact factor:   5.223


  4 in total

1.  National Interhospital Transfer for Patients With Acute Cardiovascular Conditions.

Authors:  Barry Burstein; Lior Bibas; Erin Rayner-Hartley; Jacob C Jentzer; Sean van Diepen; Michael Goldfarb
Journal:  CJC Open       Date:  2020-07-09

2.  Using the Zwolle Risk Score at Time of Coronary Angiography to Triage Patients With ST-Elevation Myocardial Infarction Following Primary Percutaneous Coronary Intervention or Thrombolysis.

Authors:  Christopher J Parr; Lorraine Avery; Brett Hiebert; Shuangbo Liu; Kunal Minhas; John Ducas
Journal:  J Am Heart Assoc       Date:  2022-02-08       Impact factor: 6.106

3.  The Healthcare Cost Burden of Acute Myocardial Infarction in Alberta, Canada.

Authors:  Dat T Tran; Arto Ohinmaa; Nguyen X Thanh; Robert C Welsh; Padma Kaul
Journal:  Pharmacoecon Open       Date:  2018-12

4.  Incidence and Predictors of Adverse Events Among Initially Stable ST-Elevation Myocardial Infarction Patients Following Primary Percutaneous Coronary Intervention.

Authors:  Jaihoon Amon; Graham C Wong; Terry Lee; Joel Singer; John Cairns; Jay S Shavadia; Christopher Granger; Kenneth Gin; Tracy Y Wang; Sean van Diepen; Christopher B Fordyce
Journal:  J Am Heart Assoc       Date:  2022-09-03       Impact factor: 6.106

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.